• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Fischer agrees to give GE Tilt-C manufacturing rights

Article

Agreement is an apparent turnabout for GESometimes, the actions of the big and powerful are beyond the comprehension of mere mortals. One of those cases may have occurred last month, when GE Medical Systems agreed to swap stock for tilting C-arm

Agreement is an apparent turnabout for GE

Sometimes, the actions of the big and powerful are beyond the comprehension of mere mortals. One of those cases may have occurred last month, when GE Medical Systems agreed to swap stock for tilting C-arm technology developed by Fischer Imaging of Denver. The deal came after years of an on-again, off-again marketing relationship between the two firms that had an unsettling impact on Fischer’s financial results.

Fischer announced March 29 that GE would exchange 62% of its preferred stock in Fischer for the nonexclusive right to manufacture the company’s Tilt-C tilting C-arm system. The companies expect that the transfer of necessary technology will be completed by mid-April, although Fischer will continue to manufacture the units for GE through the end of 1999. The transaction will give Fischer a one-time gain of roughly $6 million.

The relationship between Fischer and GE regarding Tilt-C has been rocky since its inception. In 1994, the two firms agreed that Fischer would supply GE with Tilt-C and other products. A year later, as Fischer struggled with declining revenues, Milwaukee-based GE offered Fischer $10 million in an effort to bolster the troubled firm and ensure GE’s access to Tilt-C (SCAN 7/6/95). GE’s investment included the option of taking over manufacturing of Tilt-C in exchange for Fischer preferred stock, in the event of a hostile takeover at Fischer.

But despite its ostensible commitment to Tilt-C, the number of orders GE placed for the units dropped over the next two years. This contributed to a 50% decline in Fischer’s OEM sales that wreaked havoc on the company’s financial results (SCAN 8/6/97). GE’s decision to manufacture the systems is an apparent turnaround in its position on the product, but GE executives were unavailable for comment.

From Fischer’s standpoint, last month’s deal is part of its effort to refocus the company’s energies toward whole systems rather than components, according to Morgan Nields, chairman and CEO.

“Our focus is to deemphasize manufacturing components in subsystems for other OEMs,” Nields said. “Our interest is no longer in that line of business. We’re interested in manufacturing the entire system, as well as installing and servicing it. Our goal is to move our activities down the value chain, closer to the customer.”

Since the agreement isn’t exclusive, Fischer will continue to manufacture its version of Tilt-C, and retains the right to license the technology to other entities.

© 1999 Miller Freeman, Inc.All rights reserved.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.